GrifolsWBO:GRF -0.09%83 Dividend Yield % is 1.66% as of Jun. 24, 2026, which is 21% above its 10-year median of 1.37. GuruFocus rates WBO:GRF with a GF Score™ of 83/100 and a GF Value™ of €11.06. The stock has 6 warning signs investors should review. Among 515 Drug Manufacturers companies, Grifols ranks worse than 56.7% on this metric.
As of today (2026-06-24), the Trailing Annual Dividend Yield of Grifols is 1.66%.
Good Sign:
Grifols SA stock Dividend Yield % is close to 3-year high.
The historical rank and industry rank for Grifols's Dividend Yield % or its related term are showing as below:
WBO:GRF'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.66 Med: 1.37 Max: 3.42
Current: 1.66
During the past 13 years, the highest Dividend Yield of Grifols was 3.42%. The lowest was 0.66%. And the median was 1.37%.
WBO:GRF's Dividend Yield % is ranked worse than 56.7% of 515
companies
in the Drug Manufacturers industry
Industry Median: 2.02
vs WBO:GRF: 1.66
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Grifols was 46.30% per year. The lowest was -20.00% per year. And the median was 9.75% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Grifols (WBO:GRF) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Grifols's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:GRF vs LLY, JNJ, ABBV: Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, Grifols's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grifols Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grifols's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Grifols's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Grifols Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
EUR 0.150000
2025-08-11
2025-08-12
2025-08-13
Cash Dividend
annually
EUR:EUR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Grifols's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.15
/
9.036
=
1.66 %
Current Share Price is €9.036. Grifols's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.15.
Grifols's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.15
/
9.036
=
1.66 %
Current Share Price is €9.036. Grifols's Dividends per Share for the forward twelve months is calculated as €0.15 * 1 = €0.15.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grifols (WBO:GRF) has a Dividend Yield % of 1.66% as of Jun. 24, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Grifols and its competitors. This is 21% above median its historical median of 1.37. Over the past decade, Grifols' Dividend Yield % has ranged from 0.66 to 3.42. According to the industry distribution chart, Grifols ranks #292 out of 515 companies in the Drug Manufacturers industry, placing it in the top 56.7%.
Is Grifols' Dividend Yield % too high?
Grifols' current Dividend Yield % of 1.66% is 21% above median its 10-year median of 1.37. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 3.42. The Drug Manufacturers industry median Dividend Yield % is 2.02. Grifols' value of 1.66% is 17.8% below this industry median. Based on the distribution chart, Grifols ranks #292 out of 515 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Grifols has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Grifols' Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Grifols ranks #292 out of 515 companies for Dividend Yield %. This places Grifols in the lower half of its industry. The industry median Dividend Yield % is 2.02. Grifols' value of 1.66% is 17.8% below this benchmark. Historically, Grifols' own Dividend Yield % has ranged from 0.66 to 3.42 over the past decade. While the company's 10-year median is 1.37 vs. the industry median of 2.02, Grifols has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.02, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grifols's current Dividend Yield % of 1.66% is 17.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Grifols and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grifols's current Dividend Yield % is 1.66%, which is 21% above median its own 10-year median of 1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grifols stock overvalued right now?
Grifols (WBO:GRF) has a current Dividend Yield % of 1.66%. The stock's GF Value™ is €11.06, compared to a current price of €9.04 — trading 18.3% below its estimated fair value. The current Dividend Yield % is 1.66%, which is 21% above median its 10-year median of 1.37 and 17.8% below the Drug Manufacturers industry median of 2.02. Grifols' overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Grifols (WBO:GRF), the current Dividend Yield % is 1.66% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grifols (WBO:GRF) Overvalued in 2026?
Based on GuruFocus' analysis, Grifols stock appears to be undervalued.
The current stock price of €9.04 is trading 18.3% below its estimated GF Value™ of €11.06.
Key valuation signals for WBO:GRF:
Dividend Yield %: 1.66% (21% above median its 10-year median of 1.37)
GF Value™: €11.06 vs. price of €9.04 (18.3% below fair value)
Industry Position: 17.8% below the Drug Manufacturers median (#292 of 515)
No single metric tells the full story. See the WBO:GRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
83GF Score
Get the complete analysis for WBO:GRF
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:GRF has been successfully added to your 
